ahlam1399
03-16-2016, 06:17 AM
Experts urge more cautious dosing after fatal French drug trial
LONDON (Reuters) - Researchers should be more cautious in dosing experimental medicines in early human trials, even when ***** are thought to be low risk, experts reviewing a French clinical study that left one person dead said on Wednesday.
http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/4e49e477/sc/14/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=3wgpT1Uf9ps:uQp5ZfEbQ4w:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=3wgpT1Uf9ps:uQp5ZfEbQ4w:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=3wgpT1Uf9ps:uQp5ZfEbQ4w:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=3wgpT1Uf9ps:uQp5ZfEbQ4w:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=3wgpT1Uf9ps:uQp5ZfEbQ4w:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/3wgpT1Uf9ps
LONDON (Reuters) - Researchers should be more cautious in dosing experimental medicines in early human trials, even when ***** are thought to be low risk, experts reviewing a French clinical study that left one person dead said on Wednesday.
http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/4e49e477/sc/14/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=3wgpT1Uf9ps:uQp5ZfEbQ4w:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=3wgpT1Uf9ps:uQp5ZfEbQ4w:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=3wgpT1Uf9ps:uQp5ZfEbQ4w:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=3wgpT1Uf9ps:uQp5ZfEbQ4w:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=3wgpT1Uf9ps:uQp5ZfEbQ4w:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/3wgpT1Uf9ps